ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MNTA Momenta Pharmaceuticals Inc

52.48
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Momenta Pharmaceuticals Inc NASDAQ:MNTA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 52.48 47.70 52.45 0 01:00:00

Momenta Pharmaceuticals to Webcast Presentation at the Deutsche Bank 42nd Annual Health Care Conference

26/04/2017 1:00pm

GlobeNewswire Inc.


Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Momenta Pharmaceuticals Charts.

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will present at the Deutsche Bank 42nd Annual Health Care Conference. The presentation is scheduled for Wednesday, May 3rd at 10:00 a.m. ET.

A webcast of the presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com.  A replay of the presentation will be posted on the Momenta website approximately one hour after the event.

About Momenta

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

Contact: 
Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
IR@momentapharma.com

1 Year Momenta Pharmaceuticals Chart

1 Year Momenta Pharmaceuticals Chart

1 Month Momenta Pharmaceuticals Chart

1 Month Momenta Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock